{"id":661,"date":"2023-11-02T12:56:00","date_gmt":"2023-11-02T19:56:00","guid":{"rendered":"https:\/\/hightidetx.com\/?p=661"},"modified":"2024-12-24T16:16:59","modified_gmt":"2024-12-24T08:16:59","slug":"hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash","status":"publish","type":"post","link":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/","title":{"rendered":"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c"},"content":{"rendered":"\n<p>2023\u5e7411\u67082\u65e5\uff0c\u4e2d\u56fd\u6df1\u5733\u3001\u7f8e\u56fd\u9a6c\u91cc\u5170\u5dde\u7f57\u514b\u7ef4\u5c14\u2014\u2014\u541b\u5723\u6cf0\u533b\u836f\uff08HighTide Therapeutics, Inc.\uff09\uff0c\u4e00\u5bb6\u4e13\u6ce8\u5f00\u53d1\u4ee3\u8c22\u548c\u6d88\u5316\u7cfb\u7edf\u75be\u75c5\u9886\u57df\u5168\u7403\u591a\u529f\u80fd\u3001\u591a\u9776\u70b9\u521b\u65b0\u7597\u6cd5\u7684\u533b\u836f\u516c\u53f8\uff0c\u4eca\u5929\u5ba3\u5e03\u5728\u7814\u4ea7\u54c1\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\uff08NASH\uff09\u7684\u56fd\u9645\u591a\u4e2d\u5fc3\u4e34\u5e8a2b\u671f\u7814\u7a76\uff08CENTRICITY\u7814\u7a76\uff09\u5728\u9999\u6e2f\u5a01\u5c14\u65af\u4eb2\u738b\u533b\u9662\u5b8c\u6210\u9996\u4f8b\u9999\u6e2f\u60a3\u8005\u7ed9\u836f\uff0cVincent WS Wong\uff08\u9ec4\u709c\u71ca\uff09\u6559\u6388\u62c5\u4efb\u8be5\u4e2d\u5fc3\u7684\u4e3b\u8981\u7814\u7a76\u8005\u3002<\/p>\n\n\n\n<p>CENTRICITY\u7814\u7a76\u662f\u4e00\u9879\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u7684\u5168\u7403\u591a\u4e2d\u5fc3\u4e34\u5e8a2b\u671f\u7814\u7a76\uff0c\u65e8\u5728\u8bc4\u4f30\u4e0e\u5b89\u6170\u5242\u76f8\u6bd4\uff0cHTD1801\u5bf9\u60a3\u6709\u8fdb\u5c55\u81f3\u809d\u7ea4\u7ef4\u5316\u9636\u6bb5\u7684NASH\u4f342\u578b\u7cd6\u5c3f\u75c5\uff08T2DM\uff09\u6216\u7cd6\u5c3f\u75c5\u524d\u671f\u6210\u4eba\u60a3\u8005\u7684\u809d\u810f\u7ec4\u7ec7\u5b66\u6539\u5584\u7a0b\u5ea6\u3002\u672c\u7814\u7a76\u5c06\u5165\u7ec4\u7ea6210\u540d\u7ecf\u6d3b\u68c0\u786e\u8bca\u4e3a\u60a3\u6709NASH\u4e14\u809d\u7ea4\u7ef4\u5316\u5904\u4e8e2\u671f\u62163\u671f\u7684\u6210\u5e74\u53d7\u8bd5\u8005\uff0c\u4ed6\u4eec\u5c06\u63a5\u53d7\u6700\u591a60\u5468\u7684\u6cbb\u7597\u3002<\/p>\n\n\n\n<p>\u201c\u5b8c\u6210NASH\u56fd\u9645\u591a\u4e2d\u5fc32b\u671f\u4e34\u5e8a\u8bd5\u9a8c\u9996\u4f8b\u9999\u6e2f\u60a3\u8005\u7ed9\u836f\uff0c\u6807\u5fd7\u7740NASH 2b\u671f\u7814\u7a76\u53c8\u5b9e\u73b0\u4e86\u4e00\u9879\u91cd\u5927\u91cc\u7a0b\u7891\u3002\u57fa\u4e8eHTD1801\u5728NASH\u60a3\u8005\u4e2d\u5f00\u5c55\u76842a\u671f\u4e34\u5e8a\u7814\u7a76\u53ca\u5728T2DM\u60a3\u8005\u4e2d\u5f00\u5c55\u76842\u671f\u4e34\u5e8a\u7814\u7a76\u53d6\u5f97\u7684\u79ef\u6781\u7ed3\u679c\uff0c\u6211\u4eec\u575a\u4fe1HTD1801\u5177\u5907\u6cbb\u7597NASH\u5408\u5e76T2DM\u6216\u7cd6\u5c3f\u75c5\u524d\u671f\u60a3\u8005\u7684\u6f5c\u529b\uff0c\u5e76\u62e5\u6709\u5f97\u5929\u72ec\u539a\u7684\u5168\u7403\u7ade\u4e89\u529b\uff0c\u201d\u541b\u5723\u6cf0\u7684\u9996\u5e2d\u5f00\u53d1\u5b98Leigh MacConell\u535a\u58eb\u8868\u793a\u3002<\/p>\n\n\n\n<p>\u201c\u9999\u6e2f\u7684\u7814\u7a76\u5de5\u4f5c\u5728\u5168\u7403\u591a\u4e2d\u5fc3\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u626e\u6f14\u7740\u91cd\u8981\u89d2\u8272\uff0c\u6211\u4eec\u5c06\u5168\u529b\u4ee5\u8d74\u63a8\u8fdb\u5305\u62ec\u60a3\u8005\u62db\u52df\u5728\u5185\u7684\u4e34\u5e8a\u5f00\u53d1\u8fdb\u7a0b\uff0c\u4ee5\u671f\u65e9\u65e5\u4e3a\u60a3\u8005\u63d0\u4f9b\u66f4\u52a0\u5b89\u5168\u6709\u6548\u7684\u6cbb\u7597\u9009\u62e9\uff0c\u201d\u9999\u6e2f\u5a01\u5c14\u65af\u4eb2\u738b\u533b\u9662\u7684\u4e3b\u8981\u7814\u7a76\u8005Vincent WS Wong\uff08\u9ec4\u709c\u71ca)\u6559\u6388\u8868\u793a\u3002<\/p>\n\n\n\n<p><strong>\u5173\u4e8e\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\uff08NASH\uff09<\/strong><\/p>\n\n\n\n<p>NASH\u662f\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u75c5\uff08NAFLD\uff09\u7684\u91cd\u75c7\u5f62\u5f0f\uff0c\u662f\u4e00\u79cd\u6162\u6027\u3001\u590d\u6742\u7684\u809d\u75c5\uff0c\u5176\u7279\u5f81\u662f\u809d\u810f\u708e\u75c7\u548c\u809d\u7ec6\u80de\u635f\u4f24\uff0c\u53ef\u5bfc\u81f4\u809d\u810f\u7ea4\u7ef4\u5316\u3001\u809d\u786c\u5316\u3001\u809d\u8870\u7aed\u3001\u809d\u764c\u548c\u6b7b\u4ea1\u3002NASH\u5408\u5e762\u578b\u7cd6\u5c3f\u75c5\uff08T2DM\uff09\u6216\u7cd6\u8010\u91cf\u53d7\u635f\u7684\u60a3\u8005\uff0c\u8fdb\u5c55\u4e3a\u91cd\u75c7\u7684\u98ce\u9669\u66f4\u9ad8\uff0c\u4e5f\u66f4\u53ef\u80fd\u51fa\u73b0\u5e76\u53d1\u75c7\uff0c\u5bfc\u81f4\u6b7b\u4ea1\u7387\u4e0a\u5347\u3002NASH\u7684\u60a3\u75c5\u7387\u4e0a\u5347\u8fc5\u901f\uff0c\u6b63\u5728\u8d85\u8d8a\u4e19\u578b\u809d\u708e\uff0c\u6210\u4e3a\u809d\u79fb\u690d\u7684\u9996\u8981\u75c5\u56e0\u3002\u76ee\u524d\uff0c\u5168\u7403\u5c1a\u65e0\u9488\u5bf9NASH\u7684\u836f\u7269\u83b7\u6279\u4e0a\u5e02\u3002<\/p>\n\n\n\n<p><strong>\u5173\u4e8e\u541b\u5723\u6cf0<\/strong><\/p>\n\n\n\n<p>\u541b\u5723\u6cf0\u533b\u836f\uff08HighTide Therapeutics, Inc.\uff09\u662f\u4e00\u5bb6\u5168\u7403\u4e00\u4f53\u5316\u7684\u65b0\u578b\u751f\u7269\u6280\u672f\u516c\u53f8\uff0c\u4e13\u6ce8\u4ee3\u8c22\u6027\u75be\u75c5\u3001\u6d88\u5316\u7cfb\u7edf\u75be\u75c5\u7b49\u9886\u57df\u7684\u91cd\u5927\u672a\u6ee1\u8db3\u4e34\u5e8a\u9700\u6c42\u3002\u5728\u7ecf\u9a8c\u4e30\u5bcc\u7684\u56fd\u9645\u5316\u9ad8\u7ba1\u56e2\u961f\u548c\u4e16\u754c\u4e00\u6d41\u79d1\u5b66\u987e\u95ee\u59d4\u5458\u4f1a\u9886\u5bfc\u4e0b\uff0c\u516c\u53f8\u7acb\u8db3\u6e90\u5934\u521b\u65b0\uff0c\u4ee5\u60a3\u8005\u7684\u7efc\u5408\u4e34\u5e8a\u83b7\u76ca\u548c\u6574\u4f53\u5065\u5eb7\u6539\u5584\u4e3a\u76ee\u6807\uff0c\u5f00\u53d1First-in-Class\u3001\u591a\u529f\u80fd\u3001\u591a\u9002\u5e94\u75c7\u7684\u539f\u521b\u65b0\u836f\u3002\u57fa\u4e8e\u81ea\u4e3b\u77e5\u8bc6\u4ea7\u6743\uff0c\u516c\u53f8\u5df2\u6784\u5efa\u4e30\u5bcc\u4ea7\u54c1\u7ba1\u7ebf\uff0c\u5728\u5168\u7403\u63a8\u8fdb\u591a\u9879\u4e2d\u3001\u540e\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5f00\u53d1\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\uff08NASH\uff09\u30012\u578b\u7cd6\u5c3f\u75c5\uff08T2DM\uff09\u3001\u4e25\u91cd\u9ad8\u7518\u6cb9\u4e09\u916f\u8840\u75c7\uff08SHTG\uff09\u3001\u539f\u53d1\u6027\u786c\u5316\u6027\u80c6\u7ba1\u708e\uff08PSC\uff09\u548c\u539f\u53d1\u6027\u80c6\u6c41\u6027\u80c6\u7ba1\u708e\uff08PBC\uff09\u7b49\u9002\u5e94\u75c7\u3002\u4f5c\u4e3a\u540c\u7c7b\u9996\u521b\u7684\u591a\u9776\u70b9\u65b0\u5206\u5b50\u5b9e\u4f53\uff0c\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u88ab\u7f8e\u56fdFDA\u6388\u4e882\u9879\u201c\u5feb\u901f\u901a\u9053\u8d44\u683c\u8ba4\u5b9a\u201d\u30011\u9879\u201c\u5b64\u513f\u836f\u8d44\u683c\u8ba4\u5b9a\u201d\uff0c\u5e76\u83b7\u5f97\u56fd\u5bb6\u201c\u5341\u4e09\u4e94\u201d \u201c\u91cd\u5927\u65b0\u836f\u521b\u5236\u201d\u79d1\u6280\u91cd\u5927\u4e13\u9879\u652f\u6301\u3002<\/p>\n\n\n\n<p><strong>\u524d\u77bb\u6027\u7533\u660e<\/strong><\/p>\n\n\n\n<p>\u672c\u6587\u6240\u4f5c\u51fa\u7684\u524d\u77bb\u6027\u9648\u8ff0\u4ec5\u4e0e\u672c\u6587\u4f5c\u51fa\u8be5\u9648\u8ff0\u5f53\u65e5\u7684\u4e8b\u4ef6\u6216\u8d44\u6599\u6709\u5173\u3002\u9664\u6cd5\u5f8b\u89c4\u5b9a\u5916\uff0c\u4e8e\u4f5c\u51fa\u524d\u77bb\u6027\u9648\u8ff0\u5f53\u65e5\u4e4b\u540e\uff0c\u65e0\u8bba\u662f\u5426\u51fa\u73b0\u65b0\u8d44\u6599\u3001\u672a\u6765\u4e8b\u4ef6\u6216\u5176\u4ed6\u60c5\u51b5\uff0c\u6211\u4eec\u5e76\u65e0\u8d23\u4efb\u66f4\u65b0\u6216\u516c\u5f00\u4fee\u6539\u4efb\u4f55\u524d\u77bb\u6027\u9648\u8ff0\u53ca\u9884\u6599\u4e4b\u5916\u7684\u4e8b\u4ef6\u3002\u8bf7\u7ec6\u9605\u672c\u6587\uff0c\u5e76\u7406\u89e3\u6211\u4eec\u7684\u5b9e\u9645\u672a\u6765\u4e1a\u7ee9\u6216\u8868\u73b0\u53ef\u80fd\u4e0e\u9884\u671f\u6709\u91cd\u5927\u5dee\u5f02\u3002\u672c\u6587\u5185\u6240\u6709\u9648\u8ff0\u4e43\u672c\u6587\u520a\u53d1\u65e5\u671f\u4f5c\u51fa\uff0c\u53ef\u80fd\u56e0\u672a\u6765\u53d1\u5c55\u800c\u51fa\u73b0\u53d8\u52a8\u3002<\/p>\n\n\n\n<p>\u6b32\u77e5\u66f4\u591a\u8d44\u8baf\uff0c\u656c\u8bf7\u8bbf\u95eewww.hightidetx.com<\/p>\n\n\n\n<p>\u5782\u8be2pr@hightidetx.com<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>2023\u5e7411\u67082\u65e5\uff0c\u4e2d\u56fd\u6df1\u5733\u3001\u7f8e\u56fd\u9a6c\u91cc\u5170\u5dde\u7f57\u514b\u7ef4\u5c14\u2014\u2014\u541b\u5723\u6cf0\u533b\u836f\uff08HighTide Therapeutics [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-661","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c - \u541b\u5723\u6cf0\u533b\u836f<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"zh_HK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c - \u541b\u5723\u6cf0\u533b\u836f\" \/>\n<meta property=\"og:description\" content=\"2023\u5e7411\u67082\u65e5\uff0c\u4e2d\u56fd\u6df1\u5733\u3001\u7f8e\u56fd\u9a6c\u91cc\u5170\u5dde\u7f57\u514b\u7ef4\u5c14\u2014\u2014\u541b\u5723\u6cf0\u533b\u836f\uff08HighTide Therapeutics [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/\" \/>\n<meta property=\"og:site_name\" content=\"\u541b\u5723\u6cf0\u533b\u836f\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/hightidethera\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-02T19:56:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-24T08:16:59+00:00\" \/>\n<meta name=\"author\" content=\"kaelyn\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HighTideThera\" \/>\n<meta name=\"twitter:site\" content=\"@HighTideThera\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"kaelyn\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u8a08\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/\"},\"author\":{\"name\":\"kaelyn\",\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#\/schema\/person\/579b0dcba081c4856783ae79eec74138\"},\"headline\":\"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c\",\"datePublished\":\"2023-11-02T19:56:00+00:00\",\"dateModified\":\"2024-12-24T08:16:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/\"},\"wordCount\":64,\"publisher\":{\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"zh-HK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/\",\"url\":\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/\",\"name\":\"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c - \u541b\u5723\u6cf0\u533b\u836f\",\"isPartOf\":{\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#website\"},\"datePublished\":\"2023-11-02T19:56:00+00:00\",\"dateModified\":\"2024-12-24T08:16:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/#breadcrumb\"},\"inLanguage\":\"zh-HK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.hightidetx.com\/cn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#website\",\"url\":\"https:\/\/www.hightidetx.com\/cn\/\",\"name\":\"\u541b\u5723\u6cf0\u533b\u836f\",\"description\":\"\u60a8\u7684\u5e0c\u671b\uff0c\u6211\u4eec\u7684\u4f7f\u547d\u3002\",\"publisher\":{\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.hightidetx.com\/cn\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-HK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#organization\",\"name\":\"\u541b\u5723\u6cf0\u533b\u836f\",\"url\":\"https:\/\/www.hightidetx.com\/cn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hightidetx.com\/cn\/wp-content\/uploads\/sites\/2\/2024\/12\/hidetide-logo-cn.png\",\"contentUrl\":\"https:\/\/hightidetx.com\/cn\/wp-content\/uploads\/sites\/2\/2024\/12\/hidetide-logo-cn.png\",\"width\":270,\"height\":81,\"caption\":\"\u541b\u5723\u6cf0\u533b\u836f\"},\"image\":{\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/hightidethera\/\",\"https:\/\/x.com\/HighTideThera\",\"https:\/\/www.linkedin.com\/company\/hightide-therapeutics\/posts\/?feedView=all\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.hightidetx.com\/cn\/#\/schema\/person\/579b0dcba081c4856783ae79eec74138\",\"name\":\"kaelyn\",\"url\":\"https:\/\/www.hightidetx.com\/cn\/author\/kaelyn\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c - \u541b\u5723\u6cf0\u533b\u836f","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"zh_HK","og_type":"article","og_title":"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c - \u541b\u5723\u6cf0\u533b\u836f","og_description":"2023\u5e7411\u67082\u65e5\uff0c\u4e2d\u56fd\u6df1\u5733\u3001\u7f8e\u56fd\u9a6c\u91cc\u5170\u5dde\u7f57\u514b\u7ef4\u5c14\u2014\u2014\u541b\u5723\u6cf0\u533b\u836f\uff08HighTide Therapeutics [&hellip;]","og_url":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/","og_site_name":"\u541b\u5723\u6cf0\u533b\u836f","article_publisher":"https:\/\/www.facebook.com\/hightidethera\/","article_published_time":"2023-11-02T19:56:00+00:00","article_modified_time":"2024-12-24T08:16:59+00:00","author":"kaelyn","twitter_card":"summary_large_image","twitter_creator":"@HighTideThera","twitter_site":"@HighTideThera","twitter_misc":{"\u4f5c\u8005":"kaelyn","\u9810\u8a08\u95b1\u8b80\u6642\u9593":"1 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/#article","isPartOf":{"@id":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/"},"author":{"name":"kaelyn","@id":"https:\/\/www.hightidetx.com\/cn\/#\/schema\/person\/579b0dcba081c4856783ae79eec74138"},"headline":"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c","datePublished":"2023-11-02T19:56:00+00:00","dateModified":"2024-12-24T08:16:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/"},"wordCount":64,"publisher":{"@id":"https:\/\/www.hightidetx.com\/cn\/#organization"},"articleSection":["News"],"inLanguage":"zh-HK"},{"@type":"WebPage","@id":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/","url":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/","name":"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c - \u541b\u5723\u6cf0\u533b\u836f","isPartOf":{"@id":"https:\/\/www.hightidetx.com\/cn\/#website"},"datePublished":"2023-11-02T19:56:00+00:00","dateModified":"2024-12-24T08:16:59+00:00","breadcrumb":{"@id":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/#breadcrumb"},"inLanguage":"zh-HK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hightidetx.com\/cn\/2023\/11\/02\/hightide-therapeutics-launches-clinical-trial-in-hong-kong-dosing-of-first-patient-in-ongoing-phase-2b-trial-of-berberine-ursodeoxycholate-htd1801-to-treat-nash\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hightidetx.com\/cn\/"},{"@type":"ListItem","position":2,"name":"\u541b\u5723\u6cf0\u542f\u52a8\u9999\u6e2f\u4e34\u5e8a\u5f00\u53d1\uff1a\u5b8c\u6210\u5c0f\u6a97\u78b1\u718a\u53bb\u6c27\u80c6\u9178\u76d0\uff08HTD1801\uff09\u6cbb\u7597NASH\u7684\u4e34\u5e8a2b\u671f\u7814\u7a76\u9996\u4f8b\u60a3\u8005\u7ed9\u836f\uff0c\u5168\u7403\u65b0\u836f\u5f00\u53d1\u594b\u696b\u7b03\u884c"}]},{"@type":"WebSite","@id":"https:\/\/www.hightidetx.com\/cn\/#website","url":"https:\/\/www.hightidetx.com\/cn\/","name":"\u541b\u5723\u6cf0\u533b\u836f","description":"\u60a8\u7684\u5e0c\u671b\uff0c\u6211\u4eec\u7684\u4f7f\u547d\u3002","publisher":{"@id":"https:\/\/www.hightidetx.com\/cn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hightidetx.com\/cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-HK"},{"@type":"Organization","@id":"https:\/\/www.hightidetx.com\/cn\/#organization","name":"\u541b\u5723\u6cf0\u533b\u836f","url":"https:\/\/www.hightidetx.com\/cn\/","logo":{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/www.hightidetx.com\/cn\/#\/schema\/logo\/image\/","url":"https:\/\/hightidetx.com\/cn\/wp-content\/uploads\/sites\/2\/2024\/12\/hidetide-logo-cn.png","contentUrl":"https:\/\/hightidetx.com\/cn\/wp-content\/uploads\/sites\/2\/2024\/12\/hidetide-logo-cn.png","width":270,"height":81,"caption":"\u541b\u5723\u6cf0\u533b\u836f"},"image":{"@id":"https:\/\/www.hightidetx.com\/cn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/hightidethera\/","https:\/\/x.com\/HighTideThera","https:\/\/www.linkedin.com\/company\/hightide-therapeutics\/posts\/?feedView=all"]},{"@type":"Person","@id":"https:\/\/www.hightidetx.com\/cn\/#\/schema\/person\/579b0dcba081c4856783ae79eec74138","name":"kaelyn","url":"https:\/\/www.hightidetx.com\/cn\/author\/kaelyn\/"}]}},"_links":{"self":[{"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/posts\/661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/comments?post=661"}],"version-history":[{"count":0,"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/posts\/661\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/media?parent=661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/categories?post=661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hightidetx.com\/cn\/wp-json\/wp\/v2\/tags?post=661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}